Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2026-01-05 @ 1:14 AM
Study NCT ID:
NCT06413095
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2024-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Sponsor:
Presage Biosciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MST01-MSD-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |